Peritransplant Antiviral Treatment of Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Patients.

Victoria AguileraVictoria AguileraMarino BlanesJavier MaupoeyMarina BerenguerMartín Prieto

Published in: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society (2019)

Keyphrases

human immunodeficiency virus
hepatitis c virus
antiretroviral therapy
end stage renal disease
ejection fraction
newly diagnosed
hiv infected
prognostic factors
peritoneal dialysis
hiv positive